Pipeline
China
USA
Hematology Malignancies
1: including r/r to CD19 CAR-T treatment
2: Investigator-Initiated Trial (IIT) applies to China only
1: including r/r to CD19 CAR-T treatment
2: Investigator-Initiated Trial (IIT) applies to China only